{
  "cells": [
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "gather": {
          "logged": 1711035286804
        },
        "jupyter": {
          "outputs_hidden": false,
          "source_hidden": false
        },
        "nteract": {
          "transient": {
            "deleting": false
          }
        }
      },
      "outputs": [],
      "source": [
        "%pip install -r requirements.txt"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 8,
      "metadata": {
        "gather": {
          "logged": 1721150839381
        }
      },
      "outputs": [
        {
          "data": {
            "text/plain": [
              "True"
            ]
          },
          "execution_count": 8,
          "metadata": {},
          "output_type": "execute_result"
        }
      ],
      "source": [
        "# import installed libraries\n",
        "from dotenv import load_dotenv\n",
        "import os\n",
        "import json\n",
        "from openai import AzureOpenAI\n",
        "import re\n",
        "\n",
        "\n",
        "# load environment variables\n",
        "load_dotenv(override=True)\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 21,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "c:\\Users\\szetinglau\\Documents\\Github\\IFU-translation\\data\\DRAFT_Acolad_2023 - English.md\n"
          ]
        }
      ],
      "source": [
        "# loading the markdown file\n",
        "markdown_file = os.path.join(os.getcwd(), \"data\", \"DRAFT_Acolad_2023 - English.md\")\n",
        "print(markdown_file)\n",
        "with open(markdown_file, 'r') as file:\n",
        "    data = file.read()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 25,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "['<figure>\\n\\n<!-- PageHeader=\"T Instructions for Use\" -->\\n\\n</figure>\\n\\n\\nen\\n\\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus\\nKnotless Tissue Control Device\\nAntibacterial\\nUndyed Monofilament Synthetic\\nAbsorbable Unidirectional Device\\n\\n\\n# Description\\n\\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Knotless Tissue Control Device is a sterile,\\nantibacterial monofilament, synthetic absorbable device composed of 100\\nweight percent copolymer of glycolide and E-caprolactone. The empirical\\nformula of the copolymer is (C, H, O,)_(C H O) . Poliglecaprone 25 copolymer\\nhas been found to be nonpyrogenic and elicits only a slight tissue reaction\\nduring absorption.', 'STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device contains IRGACAREÂ®+ MP\\n(triclosan), a broad spectrum antibacterial agent, at no more than 2360 Âµg/m.\\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device, Variable Loop Design consists\\nof barbed suture material, armed with a surgical needle on one end and a\\nfixation loop at the opposite end. STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device\\nis designed to anchor with a closed loop at one end and a unidirectional barbed\\nsection on the other end. STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device barbs\\nare oriented in one direction to allow tissue approximation without the need\\nto tie surgical knots.', 'While the formation of barbs in STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device\\nreduces the tensile strength relative to non-barbed suture material of the same\\nsize, tying of knots in non-barbed suture materials also reduces their effective\\nstrengths. For this reason, the strength of STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus\\nDevice can be compared to United States Pharmacopeia (USP) knot strength\\nof non-barbed sutures. USP designations for diameter are used to describe\\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device suture material after barbing,\\nexcept for minor variation in suture diameter with a maximum overage of\\n0.1 mm.\\n\\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is available in a range of gauge\\nsizes and lengths, attached to needles of various types and sizes, and in\\npresentations as described in the How Supplied section.', 'The European Pharmacopoeia (Ph. Eur.) recognizes units of measure Metric\\nand Ph. Eur. sizes as equivalent, which is reflected on the labeling. The USP\\nand Ph. Eur. sizes of STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device are further\\ndefined in Table 1.\\n\\n\\n<table>\\n<caption>Table 1. Diameter Comparison</caption>\\n<tr>\\n<th rowspan=\"2\">USP Device Size Designation</th>\\n<th>Ph. Eur. Device Size</th>\\n<th colspan=\"2\">STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus</th>\\n</tr>\\n<tr>\\n<th>(Metric/Ph.Eur.) Designation</th>\\n<th>USP</th>\\n<th>Metric/ Ph. Eur.</th>\\n</tr>\\n<tr>\\n<td>2-0</td>\\n<td>3</td>\\n<td>2-0</td>\\n<td>3</td>\\n</tr>\\n<tr>\\n<td>3-0</td>\\n<td>2</td>\\n<td>3-0</td>\\n<td>2</td>\\n</tr>\\n<tr>\\n<td>4-0</td>\\n<td>1.5</td>\\n<td>4-0</td>\\n<td>1.5</td>\\n</tr>\\n</table>\\n\\n\\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is intended for use only by\\nhealthcare professionals who are trained in surgical suturing techniques\\nincluding the use of STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device.', 'Clinical benefits expected from soft tissue approximation are to promote wound\\nhealing by primary intention.\\n\\nA summary of safety and clinical performance can be found at the following\\nlink (upon activation): https://ec.europa.eu/tools/eudamed.\\n\\n\\n## Tensile Strength\\n\\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device straight tensile strength is stronger\\nthan the knot tensile strength for a USP and EU Pharmacopoeia poliglecaprone\\n25 device of the equivalent size as shown in Table 2.\\n\\n\\n<table>\\n<caption>Table 2. Tensile Strength Comparison</caption>\\n<tr>\\n<th rowspan=\"2\">USP Device Size Designation</th>\\n<th rowspan=\"2\">Ph. Eur. Device Size (Metric/ Ph. Eur.) Designation</th>\\n<th colspan=\"2\">Device Minimum Knot Tensile Strength</th>\\n</tr>\\n<tr>\\n<th>USP (kgf)</th>\\n<th>Metric/ Ph. Eur. (N)</th>\\n</tr>\\n<tr>\\n<td>2-0</td>\\n<td>3</td>\\n<td>2.68</td>\\n<td>26.8</td>\\n</tr>\\n<tr>\\n<td>3-0</td>\\n<td>2</td>\\n<td>1.77</td>\\n<td>17.5</td>\\n</tr>\\n<tr>\\n<td>4-0</td>\\n<td>1.5</td>\\n<td>0.95</td>\\n<td>9.5</td>\\n</tr>\\n</table>', '# Indications / Intended Use\\n\\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is indicated for use in soft tissue\\napproximation where the use of absorbable sutures is appropriate.\\n\\n\\n## Contraindications\\n\\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is not to be used where extended\\napproximation of tissue under stress is required such as in fascia closure.\\nThis device is not to be used in conjunction with or for fixation of prosthetic\\ndevices (e.g., heart valves or synthetic grafts) that are non-absorbable in\\nnature. STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device should not be used in\\n\\npatients with known allergic reactions (local hypersensitivity) to IRGACAREÂ®+\\nMP (triclosan).\\n\\n\\n### Warnings', 'The safety and effectiveness of STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device\\nhave not been established in the following areas: fascial closures (including\\nabdominal wall, thoracic and extremity fascial closures), gastrointestinal\\nanastomoses, ophthalmic or microsurgery, cardiovascular, neural, osseous\\nor tendinous tissue.\\n\\nHealthcare professionals should be familiar with surgical procedures and\\ntechniques involving absorbable barbed device before employing STRATAFIXâ„¢\\nSpiral MONOCRYLâ„¢ Plus Device for wound closure, as risk of tissue separation\\n/ wound dehiscence leading to impaired healing may vary with the site\\nof application and device material used. Healthcare professionals should\\nconsider the in vivo performance (under the Performance / Actions section)\\nwhen selecting a device for use in patients.\\n\\nAcceptable surgical practice should be followed for the management of\\ncontaminated or infected wounds.', 'As this is an absorbable device, the use of supplemental non-absorbable\\nsutures should be considered by the healthcare professional in the closure of\\nthe sites that may undergo expansion, stretching or distension, or that may\\nrequire additional support.\\n\\nThe use of STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device does not substitute\\nnormal observance of hygiene and/or otherwise needed antibiotic treatment.\\n\\nHealthcare professionals should consider the quantity and quality of tissue in\\nwhich the loop will be anchored. The use of this device may be inappropriate\\nin highly vascularized tissue or fragile tissue that cannot withstand potential\\nfurther tightening/constriction within the loop.\\n\\nSmall bowel obstruction (SBO): including volvulus, bowel infarction, and\\nsignificant morbidity, have been reported due to barbs or barbed suture\\nends hooking onto adjacent small bowel and/or mesentery, such as in\\nperitoneal closure.', 'Care should be undertaken to avoid leaving barbed suture ends adjacent to\\nthe peritoneum in extra-peritoneal tissue closure.\\n\\nAvoid contacting STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device with other\\nmaterials (e.g., surgical gauze, drapes, etc.) in the surgical field to prevent\\nensnaring on the barbs. If the barbs catch, carefully pull the material in the\\nopposite direction of the needle to disengage it from the barbs.\\n\\nDo not resterilize/reuse. Reuse of this device (or portions of this device)\\nmay create a risk of product degradation that may result in device failure\\nand/or cross-contamination that may lead to infection or transmission of\\nblood-borne pathogens to patients and healthcare professionals.', 'As an absorbable device, this device may act transiently as a foreign body. As\\nwith any foreign body, prolonged contact of any device with salt solutions,\\nsuch as those found in the urinary or biliary tracts, may result in calculus\\nformation. Like all foreign bodies, STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus\\nDevice may potentiate infection.\\n\\nDiscard unintentionally opened / partially used / used devices and packages.\\n\\n\\n#### Precautions', 'STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device contains a loop end and barbs to\\nanchor tissues and does not require knots to secure the device. Tying of knots\\non the barbed section of the device will damage the barbs and potentially\\nreduce their effectiveness and may result in extended surgery time or\\ntreatment failure and additional surgery. For the device to function properly,\\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device must first be anchored by using\\nthe fixation loop in robust tissue. Then subsequently engage the barbs\\ninto the tissue in a standard closure pattern. When completing placement\\nof the barbed segment in subcuticular tissue, take at least one additional\\npass in the reverse direction to lock STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus\\nDevice in place.', 'Subcuticular devices should be placed as deeply as possible to minimize the\\nerythema and induration normally associated with the absorption process.\\nUnder some circumstances, notably orthopaedic procedures, immobilization\\nof joints by external support may be employed at the discretion of the\\nhealthcare professional. Consideration should be taken in the use of\\nabsorbable devices in tissues with poor blood supply as device extrusion and\\ndelayed absorption may occur.\\n\\nThis device may be inappropriate in elderly, malnourished or debilitated\\npatients, or in patients suffering from conditions that may delay wound healing.\\n\\nIn handling this or any other device material, care should be taken to avoid\\ndamage. Avoid crushing or crimping damage due to application of surgical\\ninstruments such as forceps or needle holders. Do not attempt to remove\\nmemory in the polymer by running fingers down the device material as this\\ncan damage the barbs.', 'Care should be taken to avoid damage when handling surgical needles.\\nGrasp the needle in an area one-third (1/3) to one-half (1/2) of the distance\\nfrom the attachment end to the point. Grasping in the point area could\\nimpair the penetration performance and cause fracture of the needle.\\nGrasping at the attachment end could cause bending or breakage.\\nReshaping needles may cause them to lose strength and be less resistant\\nto bending and breaking.\\n\\nHealthcare professionals should exercise caution when handling surgical\\nneedles to avoid inadvertent needle stick injury that may result in transmission', 'of blood-borne pathogens from contaminated needles. Broken needles\\nmay result in extended or additional surgeries or residual foreign bodies.\\nIn the event of a product malfunction before use, such as a bent, broken or\\ndetached needle, or device damage including barbs, the product should be\\ndiscarded and a new one obtained to begin the procedure. In the event of\\nproduct malfunction during use, it is up to the discretion of the healthcare\\nprofessional whether to continue or discontinue usage of the product and how\\nto complete the procedure. Refer to Application / Instructions for Use section\\nfor instructions on removal of the device.\\n\\n\\n# Adverse Reactions / Undesirable Side Effects', 'Adverse reactions associated with the use of this device include tissue\\nseparation / wound dehiscence leading to impaired healing or failure to\\nprovide adequate wound support in the closure of the sites where expansion,\\nstretching, or distension occur, and in elderly, malnourished or debilitated\\npatients or in patients suffering from other conditions that may delay wound\\nhealing. Other associated adverse events include calculus formation in urinary\\nor biliary tracts when prolonged contact with salt solutions such as urine or\\nbile occurs, transient inflammatory tissue reaction, allergic reaction (local\\nhypersensitivity) to IRGACAREÂ®+ MP (triclosan), and delayed absorption in\\ntissue with poor blood supply. Transient local irritation and suture extrusion\\nmay occur at the wound site when skin sutures are left in place for greater\\nthan 7 days. Like all foreign bodies, STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus\\nDevice may potentiate infection.', 'Device breakage may result in hemorrhage. Improper use of the device may\\ncause soft tissue injury. Damage to device during use can cause extended\\nsurgery time or treatment failure and additional surgery.\\n\\nBroken needles may result in extended or additional surgeries or residual\\nforeign bodies. Inadvertent needle sticks with contaminated surgical\\nneedles may result in the transmission of blood-borne pathogens.\\n\\nHealthcare professionals should convey adverse reactions, undesirable\\nside effects and risks associated with the product and the procedure to the\\npatient and advise the patient to contact a healthcare professional in case of\\nany deviation from the normal postoperative course.\\n\\nAny serious incident that has occurred in relation to the device should be\\nreported to the manufacturer and the country-competent authority.\\n\\n\\n## Magnetic Resonance Imaging (MRI) / Carcinogenic, Mutagenic, Toxic to Reproduction (CMR)/ Endocrine Disrupting (ED) Safety Information', 'STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is MR safe. No known CMR\\nCategory 1a/1b and ED substances are present at >0.1%. Category 1a/1b\\nare defined as known or presumed human carcinogen (H340), mutagen\\n(H350) or reproductive toxicant (H360), based on human evidence and\\nanimal studies.\\n\\n\\n### Application / Instructions for Use\\n\\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device should be selected and implanted\\ndepending on patient condition, surgical experience, surgical technique and\\nwound characteristics.\\n\\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is designed to be used in\\ncontinuous suture patterns and is intended to be used without anchoring\\nknots to begin or terminate the device line.\\nUse as required per surgical procedure.\\n\\n1\\\\. Secure the fixation loop portion to robust tissue by taking a bite in the\\ndesignated tissue, passing the needle through the loop and pulling tautly\\naround the anchoring tissue.', '2\\\\. After STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is anchored into the\\ntissue, grasp the strand and approximate tissue to the desired tension.\\nBites, or passes through the tissue, can be taken in a continuous\\nsuturing technique to approximate the wound. Care should be taken\\nto utilize STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device on the barbed\\nsegments only. Do not attempt to approximate wounds using the\\nnon-barbed segment near the needle, as the barbs are required for\\nsuccessful wound approximation with STRATAFIXâ„¢ Spiral MONOCRYLâ„¢\\nPlus Device.\\n\\n3\\\\. a. To complete the closure in subcuticular closure, take at least one pass\\nin the reverse direction. Then pass the needle across the incision and\\ntake a split-thickness bite perpendicular to the incision and exit the skin.\\nb. To complete the closure in all other tissue layers, take at least two\\npasses in the reverse direction to complete the closure.', '4\\\\. Then gently pull on the free end of the device and cut flush with\\nthe surface of the tissue.\\n\\nTo remove the entire STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device: Cut\\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device at the end anchored with the\\nloop, and then pull the distal end to remove the device.\\n\\nDiscard needles in \"sharps\" containers. Discard unintentionally opened\\n/ partially used / used devices and packages according to your facility\\'s\\npolicies and procedures concerning biohazardous materials and waste.\\n\\n\\n# Performance / Actions', 'The results of implantation studies in animals using STRATAFIXâ„¢ Spiral\\nMONOCRYLâ„¢ Plus Device indicate that approximately 62% of its original\\nstrength remains after 7 days implantation and approximately 27% of its\\noriginal tensile strength at 14 days post implantation (Table 3). All the\\noriginal tensile strength is lost by 21 days post implantation. Absorption\\nbegins as loss of tensile strength followed by a loss of mass. Absorption is\\nessentially complete between 91 and 119 days.\\n\\n\\n<table>\\n<caption>Table 3. In Vivo Tensile Strength Profile</caption>\\n<tr>\\n<th>Days Implantation</th>\\n<th>Approximate Original Strength Remaining</th>\\n</tr>\\n<tr>\\n<td>7 Days</td>\\n<td>62% of USP knot tensile strength</td>\\n</tr>\\n<tr>\\n<td>14 Days</td>\\n<td>27% of USP knot tensile strength</td>\\n</tr>\\n</table>', 'Using in vitro studies, STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device has\\nbeen shown to inhibit colonization of the device by Staphylococcus aureus,\\nStaphylococcus epidermidis, methicillin-resistant S. aureus, methicillin-\\nresistant S. epidermidis, Escherichia coli, and Klebsiella pneumoniae, which\\nare microorganisms known to be associated with surgical site infections.\\nAnimal studies have demonstrated that STRATAFIXâ„¢ Spiral MONOCRYLâ„¢\\nPlus Device inhibits bacterial colonization of the device after direct in vivo\\nchallenge with bacteria.\\n\\n\\n## Sterility\\n\\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is sterilized by ethylene oxide\\ngas. Do not resterilize. Do not use if package is opened or damaged.\\n\\n\\n### Storage\\n\\nStore at or below 30â„ƒ (86ÂºF). If the product is exposed outside specified\\nstorage range, contact manufacturer. Do not use after expiry date.\\n\\n\\n### How Supplied', 'STRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is available sterile, undyed in\\nsizes 4-0 through 2-0 (metric sizes 1.5-3.0), in a variety of lengths, with\\npermanently attached single armed needles.\\n\\nSTRATAFIXâ„¢ Spiral MONOCRYLâ„¢ Plus Device is available in one dozen units\\nper box.\\n\\n\\n### Traceability\\n\\nThe following specific information can be found on the device packaging label:\\nCatalogue number, Batch Code, expiry and manufacturing date, manufacturer\\nname, address and the website and a Unique Device Identification bar code\\nwith the Global Trade Item Number information.\\n\\n*Registered Trademark of BASF Group']\n"
          ]
        }
      ],
      "source": [
        "import re\n",
        "import textwrap\n",
        "\n",
        "def chunk_markdown(text, chunk_size=1000):\n",
        "    \"\"\"Chunks Markdown text while preserving structure (paragraphs & formatting).\"\"\"\n",
        "    paragraphs = re.split(r'(\\n\\s*\\n)', text)  # Split by double newlines (paragraphs)\n",
        "\n",
        "    chunks = []\n",
        "    current_chunk = \"\"\n",
        "\n",
        "    for para in paragraphs:\n",
        "        if len(current_chunk) + len(para) > chunk_size:\n",
        "            chunks.append(current_chunk.strip())\n",
        "            current_chunk = para\n",
        "        else:\n",
        "            current_chunk += para\n",
        "\n",
        "    if current_chunk:\n",
        "        chunks.append(current_chunk.strip())\n",
        "\n",
        "    return chunks\n",
        "\n",
        "data = chunk_markdown(data, 1000)\n",
        "print(data)"
      ]
    },
    {
      "cell_type": "markdown",
      "metadata": {},
      "source": [
        "### Initializing the Azure OpenAI Client"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 26,
      "metadata": {
        "gather": {
          "logged": 1721150850295
        }
      },
      "outputs": [],
      "source": [
        "# define openai Client\n",
        "aoai_api_key = os.getenv(\"AZURE_OPENAI_KEY\")\n",
        "aoai_api_endpoint =  os.getenv(\"AZURE_OPENAI_ENDPOINT\")\n",
        "aoai_api_deployment_name = os.getenv(\"AZURE_OPENAI_DEPLOYMENT_NAME\")\n",
        "\n",
        "client = AzureOpenAI(\n",
        "    api_key=aoai_api_key,\n",
        "    api_version=\"2024-08-01-preview\",\n",
        "    azure_endpoint=aoai_api_endpoint\n",
        ")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 34,
      "metadata": {
        "gather": {
          "logged": 1721150856670
        }
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "STRATAFIX™ Spiral MONOCRYL™ Plus\n",
            "Dispositivo de Control de Tejidos sin Nudos\n",
            "Antibacteriano\n",
            "Monofilamento Sintético No Teñido\n",
            "Dispositivo Absorbible Unidireccional\n",
            "\n",
            "# Descripción\n",
            "\n",
            "El dispositivo de control de tejidos sin nudos STRATAFIX™ Spiral MONOCRYL™ Plus es un dispositivo absorbible sintético monofilamento antibacteriano estéril, compuesto por un 100 por ciento en peso de copolímero de glicólido y E-caprolactona. La fórmula empírica del copolímero es (C, H, O,)_(C H O). Se ha encontrado que el copolímero de poliglecaprone 25 es no pirogénico y provoca solo una leve reacción tisular durante la absorción.\n",
            "\n",
            "El dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus contiene IRGACARE® MP (triclosan), un agente antibacteriano de amplio espectro, con no más de 2360 µg/m. El dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus, con diseño de bucle variable, consiste en material de sutura con barbas, equipado con una aguja quirúrgica en un extremo y un bucle de fijación en el extremo opuesto. El dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus está diseñado para anclarse con un bucle cerrado en un extremo y una sección con barbas unidireccionales en el otro extremo. Las barbas del dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus están orientadas en una dirección para permitir la aproximación de tejidos sin la necesidad de atar nudos quirúrgicos.\n",
            "\n",
            "Mientras que la formación de barbas en STRATAFIX™ Spiral MONOCRYL™ Plus Device reduce la resistencia a la tensión en comparación con el material de sutura no barbado del mismo tamaño, el atado de nudos en materiales de sutura no barbados también reduce su resistencia efectiva. Por esta razón, la resistencia de STRATAFIX™ Spiral MONOCRYL™ Plus Device puede compararse con la resistencia de nudos de la Farmacopea de los Estados Unidos (USP) de suturas no barbadas. Las designaciones de USP para el diámetro se utilizan para describir el material de sutura de STRATAFIX™ Spiral MONOCRYL™ Plus Device después de barbear, excepto por una variación menor en el diámetro de la sutura con un exceso máximo de 0.1 mm.\n",
            "\n",
            "STRATAFIX™ Spiral MONOCRYL™ Plus Device está disponible en una gama de tamaños de calibre y longitudes, adjunto a agujas de varios tipos y tamaños, y en presentaciones como se describe en la sección Cómo se Suministra.\n",
            "\n",
            "La Farmacopea Europea (Ph. Eur.) reconoce las unidades de medida métricas y los tamaños Ph. Eur. como equivalentes, lo cual se refleja en el etiquetado. Los tamaños USP y Ph. Eur. del dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus están más definidos en la Tabla 1.\n",
            "\n",
            "<table>\n",
            "<caption>Tabla 1. Comparación de Diámetros</caption>\n",
            "<tr>\n",
            "<th rowspan=\"2\">Designación del Tamaño del Dispositivo USP</th>\n",
            "<th>Tamaño del Dispositivo Ph. Eur.</th>\n",
            "<th colspan=\"2\">STRATAFIX™ Spiral MONOCRYL™ Plus</th>\n",
            "</tr>\n",
            "<tr>\n",
            "<th>Designación (Métrico/Ph.Eur.)</th>\n",
            "<th>USP</th>\n",
            "<th>Métrico/ Ph. Eur.</th>\n",
            "</tr>\n",
            "<tr>\n",
            "<td>2-0</td>\n",
            "<td>3</td>\n",
            "<td>2-0</td>\n",
            "<td>3</td>\n",
            "</tr>\n",
            "<tr>\n",
            "<td>3-0</td>\n",
            "<td>2</td>\n",
            "<td>3-0</td>\n",
            "<td>2</td>\n",
            "</tr>\n",
            "<tr>\n",
            "<td>4-0</td>\n",
            "<td>1.5</td>\n",
            "<td>4-0</td>\n",
            "<td>1.5</td>\n",
            "</tr>\n",
            "</table>\n",
            "\n",
            "El dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus está destinado para ser utilizado únicamente por profesionales de la salud que están capacitados en técnicas de sutura quirúrgica, incluyendo el uso del dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus.\n",
            "\n",
            "Los beneficios clínicos esperados de la aproximación de tejidos blandos son promover la curación de heridas por intención primaria.\n",
            "\n",
            "Un resumen de la seguridad y el rendimiento clínico se puede encontrar en el siguiente enlace (al activarse): https://ec.europa.eu/tools/eudamed.\n",
            "\n",
            "## Resistencia a la Tensión\n",
            "\n",
            "La resistencia a la tensión directa del dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus es más fuerte que la resistencia a la tensión del nudo para un dispositivo de poliglecaprone 25 de la USP y la Farmacopea de la UE de tamaño equivalente como se muestra en la Tabla 2.\n",
            "\n",
            "----------------------------------------\n",
            "\n",
            "<table>\n",
            "<caption>Tabla 2. Comparación de Resistencia a la Tensión</caption>\n",
            "<tr>\n",
            "<th rowspan=\"2\">Designación del Tamaño del Dispositivo USP</th>\n",
            "<th rowspan=\"2\">Designación del Tamaño del Dispositivo (Métrico/ Ph. Eur.)</th>\n",
            "<th colspan=\"2\">Resistencia Mínima a la Tensión del Nudo del Dispositivo</th>\n",
            "</tr>\n",
            "<tr>\n",
            "<th>USP (kgf)</th>\n",
            "<th>Métrico/ Ph. Eur. (N)</th>\n",
            "</tr>\n",
            "<tr>\n",
            "<td>2-0</td>\n",
            "<td>3</td>\n",
            "<td>2.68</td>\n",
            "<td>26.8</td>\n",
            "</tr>\n",
            "<tr>\n",
            "<td>3-0</td>\n",
            "<td>2</td>\n",
            "<td>1.77</td>\n",
            "<td>17.5</td>\n",
            "</tr>\n",
            "<tr>\n",
            "<td>4-0</td>\n",
            "<td>1.5</td>\n",
            "<td>0.95</td>\n",
            "<td>9.5</td>\n",
            "</tr>\n",
            "</table>\n",
            "\n",
            "# Indicaciones / Uso previsto\n",
            "\n",
            "El dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus está indicado para su uso en la aproximación de tejidos blandos donde sea apropiado el uso de suturas absorbibles.\n",
            "\n",
            "\n",
            "## Contraindicaciones\n",
            "\n",
            "El dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus no debe usarse donde se requiera una aproximación prolongada de tejido bajo estrés, como en el cierre de fascia. Este dispositivo no debe usarse en conjunto con o para la fijación de dispositivos protésicos (por ejemplo, válvulas cardíacas o injertos sintéticos) que son de naturaleza no absorbible. El dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus no debe usarse en pacientes con reacciones alérgicas conocidas (hipersensibilidad local) a IRGACARE® MP (triclosán).\n",
            "\n",
            "### Advertencias\n",
            "\n",
            "La seguridad y eficacia del dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus no han sido establecidas en las siguientes áreas: cierres fasciales (incluyendo pared abdominal, torácicos y cierres fasciales de extremidades), anastomosis gastrointestinal, microcirugía oftálmica o cardiovascular, neural, ósea o de tejido tendinoso.\n",
            "\n",
            "Los profesionales de la salud deben estar familiarizados con los procedimientos quirúrgicos y técnicas que involucran dispositivos absorbibles con barbas antes de utilizar el dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus para el cierre de heridas, ya que el riesgo de separación de tejidos / dehiscencia de la herida que conduce a una curación deficiente puede variar según el sitio de aplicación y el material del dispositivo utilizado. Los profesionales de la salud deben considerar el rendimiento in vivo (bajo la sección de Rendimiento / Acciones) al seleccionar un dispositivo para su uso en pacientes.\n",
            "\n",
            "Se debe seguir una práctica quirúrgica aceptable para el manejo de heridas contaminadas o infectadas.\n",
            "\n",
            "Dado que este es un dispositivo absorbible, el uso de suturas no absorbibles adicionales debería ser considerado por el profesional de la salud en el cierre de los sitios que puedan experimentar expansión, estiramiento o distensión, o que puedan requerir soporte adicional.\n",
            "\n",
            "El uso del dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus no sustituye la observancia normal de la higiene y/o el tratamiento antibiótico necesario.\n",
            "\n",
            "Los profesionales de la salud deberían considerar la cantidad y calidad del tejido en el cual se anclará el lazo. El uso de este dispositivo puede ser inapropiado en tejidos altamente vascularizados o tejidos frágiles que no puedan resistir un posible apretamiento/constricción adicional dentro del lazo.\n",
            "\n",
            "Obstrucción del intestino delgado (SBO): incluyendo vólvulo, infarto intestinal y morbilidad significativa, se han reportado debido a las púas o extremos de sutura con púas enganchándose en el intestino delgado adyacente y/o mesenterio, como en el cierre peritoneal.\n",
            "\n",
            "Se debe tener cuidado de evitar dejar extremos de sutura con púas adyacentes al peritoneo en el cierre de tejido extra-peritoneal.\n",
            "\n",
            "Evite el contacto del STRATAFIX™ Spiral MONOCRYL™ Plus Device con otros materiales (por ejemplo, gasas quirúrgicas, campos quirúrgicos, etc.) en el campo quirúrgico para prevenir que se enreden en las púas. Si las púas se enganchan, tire cuidadosamente del material en la dirección opuesta a la aguja para desengancharlo de las púas.\n",
            "\n",
            "No reesterilizar/reutilizar. La reutilización de este dispositivo (o partes de este dispositivo) puede crear un riesgo de degradación del producto que puede resultar en falla del dispositivo y/o contaminación cruzada que puede llevar a infección o transmisión de patógenos transmitidos por la sangre a pacientes y profesionales de la salud.\n",
            "\n",
            "Como un dispositivo absorbible, este dispositivo puede actuar transitoriamente como un cuerpo extraño. Al igual que con cualquier cuerpo extraño, el contacto prolongado de cualquier dispositivo con soluciones salinas, como las que se encuentran en los tractos urinario o biliar, puede resultar en la formación de cálculos. Como todos los cuerpos extraños, STRATAFIX™ Spiral MONOCRYL™ Plus Device puede potenciar la infección.\n",
            "\n",
            "Deseche los dispositivos y paquetes que se hayan abierto sin intención / parcialmente usados / usados.\n",
            "\n",
            "#### Precauciones\n",
            "\n",
            "El dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus contiene un extremo en forma de lazo y barbas para anclar tejidos y no requiere nudos para asegurar el dispositivo. Atar nudos en la sección barbada del dispositivo dañará las barbas y potencialmente reducirá su efectividad, lo que podría resultar en un tiempo de cirugía extendido o en el fracaso del tratamiento y cirugía adicional. Para que el dispositivo funcione correctamente, primero debe anclarse el STRATAFIX™ Spiral MONOCRYL™ Plus usando el lazo de fijación en tejido robusto. Luego, posteriormente, enganchar las barbas en el tejido siguiendo un patrón de cierre estándar. Al completar la colocación del segmento barbado en tejido subcuticular, realice al menos un pase adicional en dirección inversa para asegurar el dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus en su lugar.\n",
            "\n",
            "Los dispositivos subcutáneos deben colocarse lo más profundamente posible para minimizar el eritema y la induración normalmente asociados con el proceso de absorción. Bajo algunas circunstancias, notablemente en procedimientos ortopédicos, la inmovilización de las articulaciones mediante soporte externo puede ser empleada a discreción del profesional de la salud. Se debe considerar el uso de dispositivos absorbibles en tejidos con pobre suministro sanguíneo ya que puede ocurrir la extrusión del dispositivo y la absorción retardada.\n",
            "\n",
            "Este dispositivo puede ser inapropiado en pacientes ancianos, desnutridos o debilitados, o en pacientes que sufren de condiciones que pueden retrasar la cicatrización de heridas.\n",
            "\n",
            "Al manipular este u otro material de dispositivo, se debe tener cuidado para evitar daños. Evite daños por aplastamiento o pellizco debido a la aplicación de instrumentos quirúrgicos como pinzas o porta-agujas. No intente eliminar la memoria en el polímero deslizando los dedos por el material del dispositivo, ya que esto puede dañar las barbas.\n",
            "\n",
            "Se debe tener cuidado para evitar daños al manipular agujas quirúrgicas. Sujete la aguja en un área de un tercio (1/3) a la mitad (1/2) de la distancia desde el extremo de unión hasta la punta. Sujetar en el área de la punta podría perjudicar el rendimiento de penetración y causar la fractura de la aguja. Sujetar en el extremo de unión podría causar doblado o rotura. Remodelar las agujas puede hacer que pierdan fuerza y sean menos resistentes al doblado y la rotura.\n",
            "\n",
            "Los profesionales de la salud deben tener precaución al manipular agujas quirúrgicas para evitar lesiones accidentales por pinchazos de agujas que podrían resultar en la transmisión de patógenos transmitidos por la sangre a través de agujas contaminadas. Las agujas rotas pueden resultar en cirugías extendidas o adicionales o cuerpos extraños residuales. En el caso de un mal funcionamiento del producto antes de su uso, como una aguja doblada, rota o desprendida, o daño en el dispositivo incluyendo barbas, el producto debe ser descartado y obtener uno nuevo para comenzar el procedimiento. En el caso de mal funcionamiento del producto durante el uso, queda a discreción del profesional de la salud decidir si continuar o no con el uso del producto y cómo completar el procedimiento. Consulte la sección de Aplicación / Instrucciones de Uso para instrucciones sobre la eliminación del dispositivo.\n",
            "\n",
            "# Reacciones Adversas / Efectos Secundarios No Deseados\n",
            "\n",
            "Las reacciones adversas asociadas con el uso de este dispositivo incluyen la separación de tejidos / dehiscencia de la herida que conduce a una curación deficiente o la incapacidad para proporcionar un soporte adecuado de la herida en el cierre de los sitios donde ocurre expansión, estiramiento o distensión, y en pacientes ancianos, desnutridos o debilitados, o en pacientes que sufren de otras condiciones que pueden retrasar la cicatrización de la herida. Otros eventos adversos asociados incluyen la formación de cálculos en los tractos urinarios o biliares cuando ocurre un contacto prolongado con soluciones salinas como la orina o la bilis, reacción tisular inflamatoria transitoria, reacción alérgica (hipersensibilidad local) a IRGACARE®+ MP (triclosan), y absorción retardada en tejidos con pobre suministro sanguíneo. Puede ocurrir irritación local transitoria y extrusión de sutura en el sitio de la herida cuando las suturas cutáneas se dejan en su lugar por más de 7 días. Como todos los cuerpos extraños, STRATAFIX™ Spiral MONOCRYL™ Plus Device puede potenciar la infección.\n",
            "\n",
            "La rotura del dispositivo puede resultar en hemorragia. El uso inadecuado del dispositivo puede causar lesiones en los tejidos blandos. El daño al dispositivo durante su uso puede provocar un tiempo de cirugía prolongado o el fracaso del tratamiento y cirugía adicional.\n",
            "\n",
            "Las agujas rotas pueden resultar en cirugías prolongadas o adicionales o cuerpos extraños residuales. Las punciones accidentales con agujas quirúrgicas contaminadas pueden resultar en la transmisión de patógenos transmitidos por la sangre.\n",
            "\n",
            "Los profesionales de la salud deben comunicar las reacciones adversas, los efectos secundarios indeseables y los riesgos asociados con el producto y el procedimiento al paciente y aconsejar al paciente que contacte a un profesional de la salud en caso de cualquier desviación del curso postoperatorio normal.\n",
            "\n",
            "Cualquier incidente grave que haya ocurrido en relación con el dispositivo debe ser reportado al fabricante y a la autoridad competente del país.\n",
            "\n",
            "## Información de seguridad sobre Imagen por Resonancia Magnética (MRI) / Carcinogénico, Mutagénico, Tóxico para la Reproducción (CMR) / Disruptor Endocrino (ED)\n",
            "\n",
            "El dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus es seguro para RM. No se conocen sustancias CMR de la Categoría 1a/1b y ED presentes en >0.1%. Las categorías 1a/1b se definen como carcinógenos humanos conocidos o presuntos (H340), mutágenos (H350) o tóxicos reproductivos (H360), basados en evidencia humana y estudios en animales.\n",
            "\n",
            "### Aplicación / Instrucciones de Uso\n",
            "\n",
            "El dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus debe ser seleccionado e implantado dependiendo de la condición del paciente, la experiencia quirúrgica, la técnica quirúrgica y las características de la herida.\n",
            "\n",
            "El dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus está diseñado para ser utilizado en patrones de sutura continuos y está destinado a ser usado sin nudos de anclaje para comenzar o terminar la línea del dispositivo.\n",
            "Usar según sea necesario por procedimiento quirúrgico.\n",
            "\n",
            "1. Asegure la parte del lazo de fijación al tejido robusto tomando un bocado en el tejido designado, pasando la aguja a través del lazo y tirando firmemente alrededor del tejido de anclaje.\n",
            "\n",
            "2. Después de que el dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus esté anclado en el tejido, sujete la hebra y aproxime el tejido a la tensión deseada. Se pueden realizar mordidas o pasadas a través del tejido utilizando una técnica de sutura continua para aproximar la herida. Se debe tener cuidado de utilizar el dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus solo en los segmentos con barbas. No intente aproximar heridas utilizando el segmento sin barbas cerca de la aguja, ya que las barbas son necesarias para una aproximación exitosa de la herida con el dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus.\n",
            "\n",
            "3. a. Para completar el cierre en un cierre subcuticular, realice al menos una pasada en dirección inversa. Luego pase la aguja a través de la incisión y tome un mordisco de espesor parcial perpendicular a la incisión y salga de la piel.\n",
            "b. Para completar el cierre en todas las demás capas de tejido, realice al menos dos pasadas en dirección inversa para completar el cierre.\n",
            "\n",
            "4. Luego tire suavemente del extremo libre del dispositivo y córtelo al ras con la superficie del tejido.\n",
            "\n",
            "Para retirar el dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus completo: Corte el dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus en el extremo anclado con el lazo, y luego tire del extremo distal para retirar el dispositivo.\n",
            "\n",
            "Deseche las agujas en contenedores para objetos punzocortantes. Deseche los dispositivos y paquetes abiertos sin intención / parcialmente usados / usados de acuerdo con las políticas y procedimientos de su instalación concernientes a materiales y desechos biocontaminados.\n",
            "\n",
            "# Rendimiento / Acciones\n",
            "\n",
            "Los resultados de los estudios de implantación en animales utilizando STRATAFIX™ Spiral MONOCRYL™ Plus Device indican que aproximadamente el 62% de su fuerza original permanece después de 7 días de implantación y aproximadamente el 27% de su fuerza de tensión original a los 14 días después de la implantación (Tabla 3). Toda la fuerza de tensión original se pierde a los 21 días después de la implantación. La absorción comienza como pérdida de fuerza de tensión seguida por una pérdida de masa. La absorción es esencialmente completa entre 91 y 119 días.\n",
            "\n",
            "<table>\n",
            "<caption>Tabla 3. Perfil de Fuerza de Tensión In Vivo</caption>\n",
            "<tr>\n",
            "<th>Días de Implantación</th>\n",
            "<th>Fuerza Original Aproximada Restante</th>\n",
            "</tr>\n",
            "<tr>\n",
            "<td>7 Días</td>\n",
            "<td>62% de la fuerza de tensión del nudo USP</td>\n",
            "</tr>\n",
            "<tr>\n",
            "<td>14 Días</td>\n",
            "<td>27% de la fuerza de tensión del nudo USP</td>\n",
            "</tr>\n",
            "</table>\n",
            "\n",
            "Utilizando estudios in vitro, se ha demostrado que el dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus inhibe la colonización del dispositivo por Staphylococcus aureus, Staphylococcus epidermidis, S. aureus resistente a la meticilina, S. epidermidis resistente a la meticilina, Escherichia coli y Klebsiella pneumoniae, que son microorganismos conocidos por estar asociados con infecciones en el sitio quirúrgico. Los estudios en animales han demostrado que el dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus inhibe la colonización bacteriana del dispositivo después de un desafío directo in vivo con bacterias.\n",
            "\n",
            "## Esterilidad\n",
            "\n",
            "El dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus es esterilizado con gas óxido de etileno. No reesterilizar. No usar si el paquete está abierto o dañado.\n",
            "\n",
            "### Almacenamiento\n",
            "\n",
            "Almacenar a 30℃ (86ºF) o menos. Si el producto se expone fuera del rango de almacenamiento especificado, contacte al fabricante. No usar después de la fecha de caducidad.\n",
            "\n",
            "### Cómo se suministra\n",
            "\n",
            "El dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus está disponible estéril, sin teñir en tamaños de 4-0 a 2-0 (tamaños métricos 1.5-3.0), en una variedad de longitudes, con agujas de un solo brazo permanentemente adjuntas.\n",
            "\n",
            "El dispositivo STRATAFIX™ Spiral MONOCRYL™ Plus está disponible en unidades de una docena por caja.\n",
            "\n",
            "### Trazabilidad\n",
            "\n",
            "La siguiente información específica se puede encontrar en la etiqueta del empaque del dispositivo:\n",
            "Número de catálogo, Código de lote, fecha de caducidad y de fabricación, nombre del fabricante, dirección y el sitio web y un código de barras de Identificación Única del Dispositivo con información del Número de Artículo Comercial Global.\n",
            "\n",
            "*Marca Registrada de BASF Group\n"
          ]
        }
      ],
      "source": [
        "translated_chunks = []\n",
        "for chunk in data:\n",
        "    systemPrompt = f\"\"\"\n",
        "    Your Task is to translate the given text from English to Spanish:\n",
        "    Task:\n",
        "        Step 1: Translate the given text to Spanish, ensuring that the meaning (semantics) of the original text is preserved as closely as possible.\n",
        "        Step 2: Do not translate any text containing \"trademark symbols\" (™ or ®). Keep these parts as is.\n",
        "        Below is the text for translation:\n",
        "        ----------------------------------------\n",
        "\n",
        "        {chunk}\n",
        "    \"\"\"\n",
        "\n",
        "    conversaion = [\n",
        "        {\"role\": \"system\", \"content\": systemPrompt},\n",
        "        {\"role\": \"user\", \"content\": \"give me the translation in Spanish\"}\n",
        "    ]\n",
        "\n",
        "    # Send the conversation to the API\n",
        "    response = client.chat.completions.create(\n",
        "        model=aoai_api_deployment_name, # The deployment name you chose when you deployed the GPT-35-Turbo or GPT-4 model.\n",
        "        messages=conversaion,\n",
        "        temperature=0.0,\n",
        "    )\n",
        "\n",
        "    translated_chunks.append(response.choices[0].message.content)\n",
        "\n",
        "final_translation = \"\\n\\n\".join(translated_chunks) \n",
        "print(final_translation)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 35,
      "metadata": {},
      "outputs": [],
      "source": [
        "# save the responseText to a file with utf-8 encoding\n",
        "output_file = os.path.join(os.getcwd(), \"data\", \"DRAFT_Acolad_2023 - Spanish.md\")\n",
        "with open(output_file, 'w', encoding='utf-8') as file:\n",
        "    file.write(final_translation)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 36,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "c:\\Users\\szetinglau\\Documents\\Github\\IFU-translation\\data\\DRAFT_Acolad_2023 - Spanish.md\n"
          ]
        }
      ],
      "source": [
        "# loading the markdown file\n",
        "markdown_file = os.path.join(os.getcwd(), \"data\", \"DRAFT_Acolad_2023 - Spanish.md\")\n",
        "print(markdown_file)\n",
        "with open(markdown_file, 'r') as file:\n",
        "    data = file.read()"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 37,
      "metadata": {},
      "outputs": [],
      "source": [
        "data = chunk_markdown(data, 1000)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 38,
      "metadata": {},
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "STRATAFIX™ Spiral MONOCRYL™ Plus\n",
            "Knotless Tissue Control Device\n",
            "Antibacterial\n",
            "Undyed Synthetic Monofilament\n",
            "Unidirectional Absorbable Device\n",
            "\n",
            "# Description\n",
            "\n",
            "The STRATAFIX™ Spiral MONOCRYL™ Plus knotless tissue control device is a sterile antibacterial synthetic absorbable monofilament device, composed of 100 percent by weight of glycolide and E-caprolactone copolymer. The empirical formula of the copolymer is (C, H, O,)_(C H O). The poliglecaprone 25 copolymer has been found to be non-pyrogenic and causes only a mild tissue reaction during absorption.\n",
            "\n",
            "The STRATAFIX™ Spiral MONOCRYL™ Plus device contains IRGACARE® MP (triclosan), a broad-spectrum antibacterial agent, with no more than 2360 µg/m. The STRATAFIX™ Spiral MONOCRYL™ Plus device, with a variable loop design, consists of barbed suture material equipped with a surgical needle at one end and a fixation loop at the opposite end. The STRATAFIX™ Spiral MONOCRYL™ Plus device is designed to anchor with a closed loop at one end and a section with unidirectional barbs at the other end. The barbs of the STRATAFIX™ Spiral MONOCRYL™ Plus device are oriented in one direction to allow the approximation of tissues without the need to tie surgical knots.\n",
            "\n",
            "While the formation of barbs on STRATAFIX™ Spiral MONOCRYL™ Plus Device reduces tension resistance compared to non-barbed suture material of the same size, knot tying in non-barbed suture materials also reduces their effective strength. For this reason, the strength of STRATAFIX™ Spiral MONOCRYL™ Plus Device can be compared to the knot strength of the United States Pharmacopeia (USP) for non-barbed sutures. USP designations for diameter are used to describe the suture material of STRATAFIX™ Spiral MONOCRYL™ Plus Device after barbing, except for a minor variation in the diameter of the suture with a maximum excess of 0.1 mm.\n",
            "\n",
            "STRATAFIX™ Spiral MONOCRYL™ Plus Device is available in a range of gauge sizes and lengths, attached to needles of various types and sizes, and in presentations as described in the How Supplied section.\n",
            "\n",
            "The European Pharmacopoeia (Ph. Eur.) recognizes metric units of measurement and Ph. Eur. sizes as equivalent, which is reflected in the labeling. The USP and Ph. Eur. sizes of the STRATAFIX™ Spiral MONOCRYL™ Plus device are further defined in Table 1.\n",
            "\n",
            "<table>\n",
            "<caption>Table 1. Diameter Comparison</caption>\n",
            "<tr>\n",
            "<th rowspan=\"2\">USP Device Size Designation</th>\n",
            "<th>Ph. Eur. Device Size</th>\n",
            "<th colspan=\"2\">STRATAFIX™ Spiral MONOCRYL™ Plus</th>\n",
            "</tr>\n",
            "<tr>\n",
            "<th>Designation (Metric/Ph.Eur.)</th>\n",
            "<th>USP</th>\n",
            "<th>Metric/ Ph. Eur.</th>\n",
            "</tr>\n",
            "<tr>\n",
            "<td>2-0</td>\n",
            "<td>3</td>\n",
            "<td>2-0</td>\n",
            "<td>3</td>\n",
            "</tr>\n",
            "<tr>\n",
            "<td>3-0</td>\n",
            "<td>2</td>\n",
            "<td>3-0</td>\n",
            "<td>2</td>\n",
            "</tr>\n",
            "<tr>\n",
            "<td>4-0</td>\n",
            "<td>1.5</td>\n",
            "<td>4-0</td>\n",
            "<td>1.5</td>\n",
            "</tr>\n",
            "</table>\n",
            "\n",
            "The STRATAFIX™ Spiral MONOCRYL™ Plus device is intended for use solely by healthcare professionals who are trained in surgical suturing techniques, including the use of the STRATAFIX™ Spiral MONOCRYL™ Plus device.\n",
            "\n",
            "The expected clinical benefits of soft tissue approximation are to promote wound healing by primary intention.\n",
            "\n",
            "A summary of safety and clinical performance can be found at the following link (when activated): https://ec.europa.eu/tools/eudamed.\n",
            "\n",
            "## Tensile Strength\n",
            "\n",
            "The direct tensile strength of the STRATAFIX™ Spiral MONOCRYL™ Plus device is stronger than the knot tensile strength for a USP and EU Pharmacopoeia equivalent size polyglecaprone 25 device as shown in Table 2.\n",
            "\n",
            "----------------------------------------\n",
            "\n",
            "<table>\n",
            "<caption>Table 2. Comparison of Tensile Strength</caption>\n",
            "<tr>\n",
            "<th rowspan=\"2\">USP Device Size Designation</th>\n",
            "<th rowspan=\"2\">Device Size Designation (Metric/ Ph. Eur.)</th>\n",
            "<th colspan=\"2\">Minimum Tensile Strength of the Device Knot</th>\n",
            "</tr>\n",
            "<tr>\n",
            "<th>USP (kgf)</th>\n",
            "<th>Metric/ Ph. Eur. (N)</th>\n",
            "</tr>\n",
            "<tr>\n",
            "<td>2-0</td>\n",
            "<td>3</td>\n",
            "<td>2.68</td>\n",
            "<td>26.8</td>\n",
            "</tr>\n",
            "<tr>\n",
            "<td>3-0</td>\n",
            "<td>2</td>\n",
            "<td>1.77</td>\n",
            "<td>17.5</td>\n",
            "</tr>\n",
            "<tr>\n",
            "<td>4-0</td>\n",
            "<td>1.5</td>\n",
            "<td>0.95</td>\n",
            "<td>9.5</td>\n",
            "</tr>\n",
            "</table>\n",
            "\n",
            "\n",
            "# Directions / Intended Use\n",
            "\n",
            "The STRATAFIX™ Spiral MONOCRYL™ Plus device is indicated for use in the approximation of soft tissues where the use of absorbable sutures is appropriate.\n",
            "\n",
            "\n",
            "## Contraindications\n",
            "\n",
            "\n",
            "The STRATAFIX™ Spiral MONOCRYL™ Plus device should not be used where prolonged approximation of tissue under stress is required, such as in fascia closure. This device should not be used in conjunction with or for the fixation of prosthetic devices (for example, heart valves or synthetic grafts) that are non-absorbable in nature. The STRATAFIX™ Spiral MONOCRYL™ Plus device should not be used in patients with known allergic reactions (local hypersensitivity) to IRGACARE® MP (triclosan).\n",
            "\n",
            "### Warnings\n",
            "\n",
            "The safety and efficacy of the STRATAFIX™ Spiral MONOCRYL™ Plus device have not been established in the following areas: fascial closures (including abdominal wall, thoracic and limb fascial closures), gastrointestinal anastomosis, ophthalmic or cardiovascular microsurgery, neural, bone, or tendinous tissue.\n",
            "\n",
            "Healthcare professionals should be familiar with surgical procedures and techniques involving absorbable devices with barbs before using the STRATAFIX™ Spiral MONOCRYL™ Plus for wound closure, as the risk of tissue separation / wound dehiscence leading to poor healing may vary depending on the application site and the material of the device used. Healthcare professionals should consider the in vivo performance (under the Performance / Actions section) when selecting a device for use in patients.\n",
            "\n",
            "An acceptable surgical practice for managing contaminated or infected wounds should be followed.\n",
            "\n",
            "Since this is an absorbable device, the use of additional non-absorbable sutures should be considered by the healthcare professional in closing sites that may experience expansion, stretching, or distension, or that may require additional support.\n",
            "\n",
            "The use of the STRATAFIX™ Spiral MONOCRYL™ Plus device does not replace the normal observance of hygiene and/or necessary antibiotic treatment.\n",
            "\n",
            "Healthcare professionals should consider the amount and quality of the tissue in which the loop will be anchored. The use of this device may be inappropriate in highly vascularized tissues or fragile tissues that cannot withstand possible additional tightening/constriction within the loop.\n",
            "\n",
            "Small Bowel Obstruction (SBO): including volvulus, intestinal infarction, and significant morbidity, have been reported due to barbs or barbed suture ends catching on the adjacent small intestine and/or mesentery, as in peritoneal closure.\n",
            "\n",
            "Care should be taken to avoid leaving barbed suture ends adjacent to the peritoneum in the closure of extra-peritoneal tissue.\n",
            "\n",
            "Avoid contact of the STRATAFIX™ Spiral MONOCRYL™ Plus Device with other materials (for example, surgical gauzes, surgical drapes, etc.) in the surgical field to prevent them from getting tangled in the barbs. If the barbs get caught, carefully pull the material in the opposite direction of the needle to disengage it from the barbs.\n",
            "\n",
            "Do not resterilize/reuse. Reusing this device (or parts of this device) may create a risk of product degradation which could result in device failure and/or cross-contamination that may lead to infection or transmission of blood-borne pathogens to patients and healthcare professionals.\n",
            "\n",
            "As an absorbable device, this device can temporarily act as a foreign body. Like any foreign body, prolonged contact of any device with saline solutions, such as those found in the urinary or biliary tracts, may result in the formation of stones. Like all foreign bodies, STRATAFIX™ Spiral MONOCRYL™ Plus Device may enhance infection.\n",
            "\n",
            "Dispose of devices and packages that have been unintentionally opened / partially used / used.\n",
            "\n",
            "#### Precautions\n",
            "\n",
            "The STRATAFIX™ Spiral MONOCRYL™ Plus device contains an end shaped like a loop and barbs to anchor tissues and does not require knots to secure the device. Tying knots in the barbed section of the device will damage the barbs and potentially reduce its effectiveness, which could result in extended surgery time or treatment failure and additional surgery. For the device to function properly, the STRATAFIX™ Spiral MONOCRYL™ Plus must first be anchored using the fixation loop in robust tissue. Then, subsequently, hook the barbs into the tissue following a standard closure pattern. Upon completing the placement of the barbed segment in subcuticular tissue, perform at least one additional pass in the reverse direction to secure the STRATAFIX™ Spiral MONOCRYL™ Plus device in place.\n",
            "\n",
            "Subcutaneous devices should be placed as deeply as possible to minimize erythema and induration normally associated with the absorption process. Under some circumstances, notably in orthopedic procedures, immobilization of joints through external support may be employed at the discretion of the healthcare professional. The use of absorbable devices in tissues with poor blood supply should be considered since device extrusion and delayed absorption may occur.\n",
            "\n",
            "This device may be inappropriate in elderly, malnourished, or weakened patients, or in patients suffering from conditions that may delay wound healing.\n",
            "\n",
            "When handling this or other device material, care must be taken to avoid damage. Avoid crush or pinch damage due to the application of surgical instruments such as forceps or needle holders. Do not attempt to remove the memory in the polymer by sliding your fingers over the device material, as this may damage the barbs.\n",
            "\n",
            "Care must be taken to avoid damage when handling surgical needles. Hold the needle in an area one-third (1/3) to half (1/2) of the distance from the joint end to the tip. Holding in the tip area could impair penetration performance and cause the needle to fracture. Holding at the joint end could cause bending or breaking. Reshaping needles can cause them to lose strength and be less resistant to bending and breaking.\n",
            "\n",
            "Healthcare professionals should be cautious when handling surgical needles to avoid accidental needlestick injuries that could result in the transmission of bloodborne pathogens through contaminated needles. Broken needles can result in extended or additional surgeries or residual foreign bodies. In the case of product malfunction before use, such as a bent, broken, or detached needle, or damage to the device including burrs, the product should be discarded and a new one obtained to begin the procedure. In the case of product malfunction during use, it is at the discretion of the healthcare professional to decide whether to continue using the product and how to complete the procedure. Refer to the Application / Instructions for Use section for instructions on device disposal.\n",
            "\n",
            "# Adverse Reactions / Undesired Side Effects\n",
            "\n",
            "Adverse reactions associated with the use of this device include tissue separation / wound dehiscence leading to poor healing or the inability to provide adequate wound support at closure sites where expansion, stretching, or distension occurs, and in elderly, malnourished or weakened patients, or in patients suffering from other conditions that may delay wound healing. Other associated adverse events include the formation of stones in the urinary or biliary tracts when there is prolonged contact with saline solutions such as urine or bile, transient inflammatory tissue reaction, allergic reaction (local hypersensitivity) to IRGACARE®+ MP (triclosan), and delayed absorption in tissues with poor blood supply. Transient local irritation and suture extrusion at the wound site may occur when cutaneous sutures are left in place for more than 7 days. Like all foreign bodies, STRATAFIX™ Spiral MONOCRYL™ Plus Device may potentiate infection.\n",
            "\n",
            "The breakage of the device may result in bleeding. Improper use of the device can cause soft tissue injuries. Damage to the device during use may lead to prolonged surgery time or treatment failure and additional surgery.\n",
            "\n",
            "Broken needles may result in prolonged or additional surgeries or residual foreign bodies. Accidental punctures with contaminated surgical needles may result in the transmission of blood-borne pathogens.\n",
            "\n",
            "Healthcare professionals should communicate adverse reactions, undesirable side effects, and risks associated with the product and procedure to the patient and advise the patient to contact a healthcare professional in case of any deviation from the normal postoperative course.\n",
            "\n",
            "Any serious incident that has occurred in relation to the device should be reported to the manufacturer and to the competent authority of the country.\n",
            "\n",
            "## Safety Information on Magnetic Resonance Imaging (MRI) / Carcinogenic, Mutagenic, Reproductive Toxicant (CMR) / Endocrine Disruptor (ED)\n",
            "\n",
            "The STRATAFIX™ Spiral MONOCRYL™ Plus device is safe for MRI. There are no known CMR substances of Category 1a/1b and ED present in >0.1%. Categories 1a/1b are defined as known or presumed human carcinogens (H340), mutagens (H350), or reproductive toxicants (H360), based on human evidence and animal studies.\n",
            "\n",
            "### Application / Instructions for Use\n",
            "\n",
            "The STRATAFIX™ Spiral MONOCRYL™ Plus device should be selected and implanted depending on the patient's condition, surgical experience, surgical technique, and wound characteristics.\n",
            "\n",
            "The STRATAFIX™ Spiral MONOCRYL™ Plus device is designed for use in continuous suture patterns and is intended to be used without anchoring knots to start or end the device line.\n",
            "Use as needed by surgical procedure.\n",
            "\n",
            "1. Secure the loop part of the fixation to the robust tissue by taking a bite in the designated tissue, passing the needle through the loop, and pulling firmly around the anchor tissue.\n",
            "\n",
            "2. After the STRATAFIX™ Spiral MONOCRYL™ Plus device is anchored in the tissue, hold the strand and bring the tissue to the desired tension. Bites or passes can be made through the tissue using a continuous suturing technique to approximate the wound. Care must be taken to use the STRATAFIX™ Spiral MONOCRYL™ Plus device only on the segments with barbs. Do not attempt to approximate wounds using the barbless segment near the needle, as the barbs are necessary for a successful wound approximation with the STRATAFIX™ Spiral MONOCRYL™ Plus device.\n",
            "\n",
            "3. a. To complete the closure in a subcuticular stitch, make at least one pass in the reverse direction. Then pass the needle through the incision and take a partial thickness bite perpendicular to the incision and exit the skin.\n",
            "b. To complete the closure in all other tissue layers, make at least two passes in the reverse direction to complete the closure.\n",
            "\n",
            "4. Then gently pull the free end of the device and cut it flush with the tissue surface.\n",
            "\n",
            "To remove the STRATAFIX™ Spiral MONOCRYL™ Plus device: Cut the STRATAFIX™ Spiral MONOCRYL™ Plus device at the anchored end with the loop, and then pull the distal end to remove the device.\n",
            "\n",
            "Dispose of needles in sharps containers. Dispose of devices and opened / unintentionally partially used / used packages in accordance with your facility's policies and procedures concerning biocontaminated materials and waste.\n",
            "\n",
            "# Performance / Actions\n",
            "\n",
            "The results of implantation studies in animals using STRATAFIX™ Spiral MONOCRYL™ Plus Device indicate that approximately 62% of its original strength remains after 7 days of implantation and approximately 27% of its original tensile strength at 14 days after implantation (Table 3). All original tensile strength is lost 21 days after implantation. Absorption begins as a loss of tensile strength followed by a loss of mass. Absorption is essentially complete between 91 and 119 days.\n",
            "\n",
            "<table>\n",
            "<caption>Table 3. In Vivo Tensile Strength Profile</caption>\n",
            "<tr>\n",
            "<th>Days of Implantation</th>\n",
            "<th>Approximate Remaining Original Strength</th>\n",
            "</tr>\n",
            "<tr>\n",
            "<td>7 Days</td>\n",
            "<td>62% of the USP knot tensile strength</td>\n",
            "</tr>\n",
            "<tr>\n",
            "<td>14 Days</td>\n",
            "<td>27% of the USP knot tensile strength</td>\n",
            "</tr>\n",
            "</table>\n",
            "\n",
            "Using in vitro studies, it has been demonstrated that the STRATAFIX™ Spiral MONOCRYL™ Plus device inhibits colonization of the device by Staphylococcus aureus, Staphylococcus epidermidis, methicillin-resistant S. aureus, methicillin-resistant S. epidermidis, Escherichia coli, and Klebsiella pneumoniae, which are microorganisms known to be associated with surgical site infections. Animal studies have shown that the STRATAFIX™ Spiral MONOCRYL™ Plus device inhibits bacterial colonization of the device after a direct in vivo challenge with bacteria.\n",
            "\n",
            "## Sterility\n",
            "\n",
            "The STRATAFIX™ Spiral MONOCRYL™ Plus device is sterilized with ethylene oxide gas. Do not resterilize. Do not use if the package is open or damaged.\n",
            "\n",
            "### Storage\n",
            "\n",
            "Store at 30°C (86°F) or less. If the product is exposed outside the specified storage range, contact the manufacturer. Do not use after the expiration date.\n",
            "\n",
            "### How it is supplied\n",
            "\n",
            "The STRATAFIX™ Spiral MONOCRYL™ Plus device is available sterile, undyed in sizes from 4-0 to 2-0 (metric sizes 1.5-3.0), in a variety of lengths, with permanently attached single-arm needles.\n",
            "\n",
            "The STRATAFIX™ Spiral MONOCRYL™ Plus device is available in units of a dozen per box.\n",
            "\n",
            "### Traceability\n",
            "\n",
            "The following specific information can be found on the device packaging label:\n",
            "Catalog number, batch code, expiration and manufacturing date, manufacturer's name, address and website, and a Unique Device Identification barcode with Global Trade Item Number information.\n",
            "\n",
            "*Registered Trademark of BASF Group\n"
          ]
        }
      ],
      "source": [
        "translated_chunks = []\n",
        "for chunk in data:\n",
        "    systemPrompt = f\"\"\"\n",
        "    Your Task is to translate the given text from Spanish to English:\n",
        "    Task:\n",
        "        Step 1: Translate the given text to English, ensuring that the meaning (semantics) of the original text is preserved as closely as possible.\n",
        "        Step 2: Do not translate any text containing \"trademark symbols\" (™ or ®). Keep these parts as is.\n",
        "        Below is the text for translation:\n",
        "        ----------------------------------------\n",
        "\n",
        "        {chunk}\n",
        "    \"\"\"\n",
        "\n",
        "    conversaion = [\n",
        "        {\"role\": \"system\", \"content\": systemPrompt},\n",
        "        {\"role\": \"user\", \"content\": \"give me the translation in English\"}\n",
        "    ]\n",
        "\n",
        "    # Send the conversation to the API\n",
        "    response = client.chat.completions.create(\n",
        "        model=aoai_api_deployment_name, # The deployment name you chose when you deployed the GPT-35-Turbo or GPT-4 model.\n",
        "        messages=conversaion,\n",
        "        temperature=0.0,\n",
        "    )\n",
        "\n",
        "    translated_chunks.append(response.choices[0].message.content)\n",
        "\n",
        "final_translation = \"\\n\\n\".join(translated_chunks) \n",
        "print(final_translation)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 39,
      "metadata": {},
      "outputs": [],
      "source": [
        "# save the responseText to a file with utf-8 encoding\n",
        "output_file = os.path.join(os.getcwd(), \"data\", \"DRAFT_Acolad_2023_V2 - English.md\")\n",
        "with open(output_file, 'w', encoding='utf-8') as file:\n",
        "    file.write(final_translation)"
      ]
    }
  ],
  "metadata": {
    "kernel_info": {
      "name": "newenvtf"
    },
    "kernelspec": {
      "display_name": "Python 3",
      "language": "python",
      "name": "python3"
    },
    "language_info": {
      "codemirror_mode": {
        "name": "ipython",
        "version": 3
      },
      "file_extension": ".py",
      "mimetype": "text/x-python",
      "name": "python",
      "nbconvert_exporter": "python",
      "pygments_lexer": "ipython3",
      "version": "3.11.9"
    },
    "microsoft": {
      "host": {
        "AzureML": {
          "notebookHasBeenCompleted": true
        }
      },
      "ms_spell_check": {
        "ms_spell_check_language": "en"
      }
    },
    "nteract": {
      "version": "nteract-front-end@1.0.0"
    }
  },
  "nbformat": 4,
  "nbformat_minor": 2
}
